These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 8647949)
1. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators. Salvemini D; Currie MG; Mollace V J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949 [TBL] [Abstract][Full Text] [Related]
2. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate. Marks GS; McLaughlin BE; Jimmo SL; Poklewska-Koziell M; Brien JF; Nakatsu K Drug Metab Dispos; 1995 Nov; 23(11):1248-52. PubMed ID: 8591726 [TBL] [Abstract][Full Text] [Related]
3. Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin. Gryglewski RJ; Zembowicz A; Salvemini D; Taylor GW; Vane JR Br J Pharmacol; 1992 Aug; 106(4):838-45. PubMed ID: 1327388 [TBL] [Abstract][Full Text] [Related]
4. Vasorelaxant and platelet-suppressant potencies of four NO-donors. Zembowicz A; Dudek RD; Radziszewski W; Swierkosz TA; Trybulec M; Gryglewski RJ Pol J Pharmacol Pharm; 1990; 42(3):275-81. PubMed ID: 2124687 [TBL] [Abstract][Full Text] [Related]
5. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Maurice DH; Haslam RJ Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060 [TBL] [Abstract][Full Text] [Related]
6. Nitric oxide as a regulator of prostacyclin synthesis in cultured rat heart endothelial cells. Sievi E; Lähteenmäki TA; Alanko J; Vuorinen P; Vapaatalo H Arzneimittelforschung; 1997 Oct; 47(10):1093-8. PubMed ID: 9368700 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide. Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms. Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301 [TBL] [Abstract][Full Text] [Related]
9. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide. Klinge JM; Topf HG; Trusen B; Rauh M; Rascher W; Dötsch J Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo. Gerzer R; Drummer C; Karrenbrock B; Heim JM J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S115-9. PubMed ID: 2484688 [TBL] [Abstract][Full Text] [Related]
11. [Inhibition of platelet activation by endothelium-derived relaxing factor EDRF/NO and NO releasing dilator substances]. Bassenge E Z Kardiol; 1991; 80 Suppl 5():17-21. PubMed ID: 1776330 [TBL] [Abstract][Full Text] [Related]
12. Nitric oxide and prostacyclin modulate the alterations in cardiac action potential duration mediated by platelets during ischaemia. Goulielmos NV; Enayat ZE; Sheridan DJ; Cohen H; Flores NA Cardiovasc Res; 1995 Nov; 30(5):788-98. PubMed ID: 8595628 [TBL] [Abstract][Full Text] [Related]
13. Intestinal absorption of calcium in vivo is dependent on endogenous nitric oxide. Schleiffer R; Galluser M; Raul F J Pharmacol Exp Ther; 1995 Dec; 275(3):1427-32. PubMed ID: 8531112 [TBL] [Abstract][Full Text] [Related]
14. Inhibition by nitric oxide-releasing compounds of prostacyclin production in human endothelial cells. Kosonen O; Kankaanranta H; Malo-Ranta U; Ristimäki A; Moilanen E Br J Pharmacol; 1998 Sep; 125(2):247-54. PubMed ID: 9786495 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of the catalytic activity of alcohol dehydrogenase by nitric oxide is associated with S nitrosylation and the release of zinc. Gergel D; Cederbaum AI Biochemistry; 1996 Dec; 35(50):16186-94. PubMed ID: 8973191 [TBL] [Abstract][Full Text] [Related]
16. Nitric oxide donors and angiotensin-converting enzyme inhibitors act in concert to inhibit human angiotensin-converting enzyme activity and platelet aggregation in vitro. Persson K; Whiss PA; Nyhlén K; Jacobsson-Strier M; Glindell M; Andersson RG Eur J Pharmacol; 2000 Oct; 406(1):15-23. PubMed ID: 11011027 [TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of cyclooxygenase-2 enhances platelet adhesion in hamster arterioles in vivo. Buerkle MA; Lehrer S; Sohn HY; Conzen P; Pohl U; Krötz F Circulation; 2004 Oct; 110(14):2053-9. PubMed ID: 15451781 [TBL] [Abstract][Full Text] [Related]
18. [Endothelial factors and thrombocyte function]. Schrör K Z Kardiol; 1991; 80 Suppl 5():3-6. PubMed ID: 1776333 [TBL] [Abstract][Full Text] [Related]
19. In vivo depletion of free thiols does not account for nitroglycerin-induced tolerance: a thiol-nitrate interaction hypothesis as an alternative explanation for nitroglycerin activity and tolerance. Haj-Yehia AI; Benet LZ J Pharmacol Exp Ther; 1996 Sep; 278(3):1296-305. PubMed ID: 8819515 [TBL] [Abstract][Full Text] [Related]
20. Glyceryl trinitrate-induced vasodilation is inhibited by ultraviolet irradiation despite enhanced nitric oxide generation: evidence for formation of a nitric oxide conjugate. Hussain AS; Crispino NH; McLaughlin BE; Brien JF; Marks GS; Nakatsu K J Pharmacol Exp Ther; 1999 May; 289(2):895-900. PubMed ID: 10215668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]